Journal: The EMBO Journal
Article Title: Functional rescue of a disease-linked ERAD pathway mutation via alternative splicing
doi: 10.1038/s44318-026-00757-5
Figure Lengend Snippet: ( A – C ) Western blot analysis of SEL1L protein expression ( A ), HRD1 and ERAD substrate IRE1α ( B ) in mouse brains or cortex at indicated ages, with quantification in ( C ). n = 3–4 mice/group. SEL1L: WT vs. HET, P = 0.057; WT vs. KI, *** P = 0.0006; HRD1: WT vs. HET, P = 0.52; WT vs. KI, ** P = 0.0017; IRE1α: WT vs. HET, P = 0.99; WT vs. KI, **** P < 0.0001. ( D , E ) Western blot analysis ( D ) of ERAD protein and ERAD substrates from WT and KI’ mice brain with quantification shown in ( E ). n = 3–4 mice/group. SEL1L: WT vs. KI’, *** P = 0.0009; HRD1: WT vs. KI’, P = 0.34; IRE1α: WT vs. KI’, P = 0.28. ( F ) Phos-tag gel analysis of IRE1α phosphorylation in p0 WT, HET and KI brains. n = 3–4 mice/group. ( G ) RT-PCR analysis of Xbp1 mRNA splicing of p0 WT, KI, and KI’ brains with quantification in Fig. . n = 3–6 mice/group, 3–4 for positive controls. u, unspliced. s, spliced. ( H , I ) Immunofluorescence ( H ) of SATB2+ Layer II/III cells and the CTIP2+ Layer V in the cortex of p0 WT, KI and KI’ mice, with zoom-in region showing SATB2+ cells below Layer V and with quantification shown in ( I ). n = 3–6 mice/group. Green, CTIP2; Red, SATB2; Blue, DAPI. WT vs. KI, * P = 0.046; WT vs. KI’, * P = 0.032; KI vs. KI’, *** P = 0.0007. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by one-way ANOVA followed by Tukey’s post hoc test for ( C , I ); two-tailed t test for ( E ). .
Article Snippet: ProLongTM Diamond Antifade Mountant with DAPI , Fisher Scientific , P36971.
Techniques: Western Blot, Expressing, Phospho-proteomics, Reverse Transcription Polymerase Chain Reaction, Immunofluorescence, Two Tailed Test